CD137 ACTIVATION AUGMENTS THE EFFICACY OF EGFR-TARGETED THERAPY

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2014年 / 4卷 / 07期
关键词：
D O I：
10.1158/2159-8290.CD-RW2014-120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Major finding: Treatment with anti-CD137 mAb improves cetuximab efficacy by enhancing immune responses. Mechanism: Cetuximab induces CD137 on NK cells, and CD137 targeting stimulates ADCC and adaptive immunity. Impact: Dual antibody therapy may be beneficial in EGFR-positive cancers, including KRAS-mutant tumors. © 2014 American Association for Cancer Research.
引用
收藏
页码：758 / 758
页数：1
相关论文
共 50 条
  • [31] Engineering of EGFR-targeted nanoparticles for triple negative breast cancer therapy
    Zhang, Xueqing
    Xu, Xiaoyang
    Ho, Dean
    Lam, Robert
    Qin, Lidong
    CANCER RESEARCH, 2012, 72
  • [32] EGFR-targeted gold liposome for molecular imaging and therapy on NSCLC cells
    Yokoyama, Tomohisa
    Osato, Yoichi
    Miyazawa, Keisuke
    Miyasato, Akime
    Hayabe, Hiroko
    Nomura, Masaharu
    Gotoh, Noriko
    Itoi, Takao
    Tauchi, Tetsuzo
    Ikeda, Norihiko
    Ohyashiki, Kazuma
    CANCER RESEARCH, 2012, 72
  • [33] Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist
    Upadhyaya, Punit
    Lahdenranta, Johanna
    Hurov, Kristen
    Battula, Sailaja
    Dods, Rachel
    Haines, Eric
    Kleyman, Marianna
    Kristensson, Julia
    Kublin, Jessica
    Lani, Rachid
    Ma, Jun
    Mudd, Gemma
    Repash, Elizabeth
    Van Rietschoten, Katerine
    Stephen, Tom
    You, Fanglei
    Harrison, Helen
    Chen, Liuhong
    McDonnell, Kevin
    Brandish, Philip
    Keen, Nicholas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (01)
  • [34] Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy
    Mittal, Payal
    St Rose, Marie-Clare
    Wang, Xi
    Ryan, Joseph M.
    Wasser, Jeffrey S.
    Vella, Anthony T.
    Adler, Adam J.
    JOURNAL OF IMMUNOLOGY, 2015, 195 (12): : 5816 - 5826
  • [35] EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer
    Tulchinsky, Eugene
    Demidov, Oleg
    Kriajevska, Marina
    Barlev, Nickolai A.
    Imyanitov, Evgeny
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1871 (01): : 29 - 39
  • [36] Expression of CD137 Protein in Select Hematopoietic Tumors: Implications for Anti-CD137 Immunomodulatory Therapy
    Anderson, M. W.
    Freud, A. G.
    Zhao, S.
    Alizadeh, A. A.
    Kohrt, H. E.
    Warnke, R.
    Levy, R.
    Natkunam, Y.
    LABORATORY INVESTIGATION, 2011, 91 : 285A - 285A
  • [37] Hair eruption initiates adverse events of EGFR-targeted cancer therapy
    Jin, R.
    Klufa, J.
    Strobl, K.
    Artner-Gent, L.
    Farlik, M.
    Sibilia, M.
    Bauer, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S362 - S362
  • [38] Transcriptional modules predicting response of colorectal cancer to EGFR-targeted therapy
    Medico, E.
    Picco, G.
    Isella, C.
    Petti, C.
    EJC SUPPLEMENTS, 2010, 8 (05): : 201 - 201
  • [39] Adaptive Resistance to EGFR-Targeted Therapy by Calcium Signaling in NSCLC Cells
    Mulder, Celine
    Prust, Nadine
    van Doorn, Sander
    Reinecke, Maria
    Kuster, Bernhard
    Henegouwen, Paul van Bergen En
    Lemeer, Simone
    MOLECULAR CANCER RESEARCH, 2018, 16 (11) : 1773 - 1784
  • [40] Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma
    Cassell, Andre
    Grandis, Jennifer R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (06) : 709 - 722
12345